Ovid Therapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Ovid Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Ovid Therapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ovid Therapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 925k | 1.30 |
| 2025-06-30 | $144k | 436k | 0.33 |
| 2025-03-31 | $175k | 561k | 0.31 |
| 2024-12-31 | $66k | 70k | 0.93 |
| 2024-09-30 | $102k | 86k | 1.18 |
| 2024-03-31 | $349k | 114k | 3.05 |
| 2023-12-31 | $253k | 79k | 3.22 |
| 2022-06-30 | $57k | 26k | 2.16 |
| 2021-09-30 | $1.1M | 335k | 3.36 |
| 2020-06-30 | $3.8M | 510k | 7.37 |
| 2020-03-31 | $358k | 120k | 2.98 |
| 2019-12-31 | $274k | 66k | 4.16 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management